Skip to main content

Reducing the number of sputum samples examined and thresholds for positivity: an opportunity to optimise smear microscopy

Buy Article:

$34.78 + tax (Refund Policy)

SETTING: Urban health clinic, Nairobi.

OBJECTIVE: To evaluate the impact on tuberculosis (TB) case detection and laboratory workload of reducing the number of sputum smears examined and thresholds for diagnosing positive smears and positive cases.

DESIGN: In this prospective study, three Ziehl-Neelsen stained sputum smears from consecutive pulmonary TB suspects were examined blind. The standard approach (A), ≥2 positive smears out of 3, using a cut-off of 10 acid-fast bacilli (AFB)/100 high-power fields (HPF), was compared with approaches B, ≥2 positive smears (≥4 AFB/100 HPF) out of 3, one of which is ≥10 AFB/100 HPF; C, ≥2 positive smears (≥4 AFB/100 HPF) out of 3; D, ≥1 positive smear (≥10 AFB/100 HPF) out of 2; and E, ≥1 positive smear (≥4 AFB/100 HPF) out of 2. The microscopy gold standard was detection of at least one positive smear (≥4 AFB/100 HPF) out of 3.

RESULTS: Among 644 TB suspects, the alternative approaches detected from 114 (17.7%) (approach B) to 123 cases (19.1%) (approach E) compared to 105 cases (16.3%) for approach A (P < 0.005). Sensitivity ranged between 82.0% (105/128) for A and 96.1% (123/128) for E. The single positive smear approaches reduced the number of smears by 36% compared to approach A.

CONCLUSION: Reducing the number of specimens and the positivity threshold to define a positive case increased the sensitivity of microscopy and reduced laboratory workload.

Keywords: diagnosis; microscopy; tuberculosis

Document Type: Regular Paper

Affiliations: 1: Epicentre, Paris, France 2: Liverpool School of Tropical Medicine, Liverpool, UK 3: Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi Kenya 4: Médecins Sans Frontières, Paris, France

Publication date: 01 September 2007

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content